71
DAFTAR PUSTAKA
Abbas, A., Lichtman, A. H., dan Pober, J. S. (2005). Cellular and Molecular
Immunology. Edisi V. Philadelphia: W. B. Saunders. Halaman 90-92.
Albariyah, T. (2009). Studi Interaksi Obat Kemoterapi dengan Obat Penunjangnya pada Protokol Kemoterapi Kanker Anak di Rumah Sakit Kanker Dharmais. Indonesian Journal of Cancer. 3(2): 53-58.p
Anonima. (2009). Rumah Sakit Kanker Dharmais: Informasi Kanker dan Pasien. Diakses dari http://www.dharmais.co.id pada tanggal 9 Agustus 2014.
Anonimb. (2013). Treatment for Breast Cancer. Diakses dari http://www. macmillan.org.uk/Cancerinformation/Cancertypes/Breast/Treatingbreast cancer/Treatmentoverview.aspx pada tanggal 1 Januari 2015.
Anonimc. (2014). Drug Bank: Interax Drug Interaction Lookup. Diakses dari http://www.drugbank.ca/interax/drug_lookup pada tanggal 9 Agustus 2014.
Ashton, P., Giacomazzi, J., Schmidt, A. V., Roth, F. L., Palmero, E. I., Kalakun, L., et al. (2009). Development and Validation of a Simple Questionnaire for the Identification of Hereditary Breast Cancer in Primary Care. BMC
Cancer. 9: 283.
Balducci, L. (2009). Pharmacology of Antineoplastic Medications in Older
Cancer Patients. Diakses dari
http://www.cancernetwork.com/oncology-journal/pharmacology-antineoplastic-medications-older-cancer-patients pada tanggal 9 Agustus 2014.
Bast, C. R. (1985). Principles of Cancer Biology: Tumor Immunology. Dalam: DeVita, V. T. Jr., Hellman, S., dan Rosenberg, S. A., editor. Cancer:
Principles & Practice of Oncology. Philadelphia: J. B. Lippincott.
Halaman 125-141.
72
Brody, J. G., dan Rudel, R. A. (2003). Environmental Pollutants and Breast Cancer In Research Review. Environmental Health Perspective. 111(8): 1007-1019.
Bykov, V. J., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., et al. (2002). Restoration of the Tumor Suppressor Function to Mutant p53 by a Low-Molecular-Weight Compound. Nature Medicine. 8(3): 282-288.
Cagnoni, P. J., Matthes, S., Day, T. C., Bearman, S. I., Shpall, E. J., dan Jones, R. B. (1999). Modification of the Pharmacokinetics of High-Dose Cyclophosphamide and Cisplatin by Antiemetics. Bone Marrow
Transplantation. 24(1): 1-4.
Calabresi, P., dan Chabner, B. A. (2003). Kemoterapi Penyakit Neoplastik. Dalam: Hardman, J. G., dan Limbird, L. E., editor. Goodman & Gilman:
Dasar Farmakologi Terapi Volume 2. Edisi X. Jakarta: Penerbit Buku
Kedokteran EGC. Halaman 1353-1357, 1366, 1394.
Chandrasoma, C., dan Taylor, C. R. (1995). Concise Pathology. Edisi II. London: Prentice Hall International, Inc. Halaman 812-813.
Chapoval, A. I., Fuller, J. A., Kremlev, S. G., Kamdar, S. J. dan Evans, R. (1998). Combination Chemotherapy and IL-15 Administration Induce Permanent Tumor Regression in a Mouse Lung Tumor Model: NK and T Cell-Mediated Effects Antagonized by B cell. Journal of Immunology. 161(12): 6977-6984.
Cipolle, J. R., Strand, L., dan Morley, C. P. (2004). Pharmaceutical Care
Practice: The Clinician’s Guide. Edisi II. New York: McGraw-Hill.
Halaman 178-179.
Damayanti, S. M. (2006). Evaluasi Penatalaksaan Mual-Muntah pada Kasus Kanker Payudara Pascakemoterapi di Rumah Sakit Panti Rapih Yogyakarta Periode Januari 2004 – Juni 2005. Skripsi Program Studi Farmasi Universitas Sanata Dharma Yogyakarta. Halaman 13-14, 31-44, 63.
Dhesi, S., Chu, M. P., Blevins, G., Paterson, I., Larratt, L., Oudit, G. Y., et al. (2013). Cyclophosphamide-Induced Cardiomyopathy: A Case Report, Review, and Recommendations for Management. Journal of Investigate
Medicine High Impact Case Reports January-March 2013. 1(1): 1-7.
73
Gilbert, C. J., Petros, W. P., Vredenburgh, J., Hussein, A., Ross, M., Rubin, P., et al. (1998). Pharmacokinetic Interaction Between Ondansetron and Cyclophosphamide During High-Dose Chemotherapy for Breast Cancer.
Cancer Chemotherapy and Pharmacology. 42(6): 497-503.
Indrati, R. (2005). Faktor-faktor Risiko yang Berpengaruh terhadap Kejadian Kanker Payudara Wanita. Tesis Program Studi Magister Epidemiologi Universitas Diponegoro Semarang. Halaman 1, 4-5.
International Research Cancer Agency. (2012). Breast Cancer: Estimated
Incidence, Mortality and Prevalence Worldwide in 2012. Diakses dari
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=breast pada tanggal 1 April 2014.
Joy, M. S., La, M., Wang, J., Bridges, A. S., Hu, Y., Hogan, S. L., et al. (2012). Cyclophosphamide and 4-hydroxycyclophosphamide Pharmacokinetics in Patients with Glomerulonephritis Secondary to Lupus and Small Vessel Vasculitis. British Journal of Clinical Pharmacology. 74(3): 445-455.
Joerger, A. C., Ang, H. C., Veprintsev, D. B., Blair, C. M., dan Fersht, A. R. (2005). Structure of p53 Cancer Mutants and Mechanism or Rescue by Second-site Suppressor Mutations. The Journal of Biological Chemistry. 280(3): 16030.
Junqueira, L. C., Carneiro, J., dan Kelley, R. O. (1995). Basic Histology. Edisi VIII. London: Prentice Hall International, Inc. Halaman 423-446.
Kar, A. S. (2005). Pengaruh Anemia pada Kanker terhadap Kualitas Hidup dan Hasil Pengobatan. Pidato Pengukuhan Jabatan Guru Besar Tetap dalam Bidang Ilmu Penyakit Dalam pada Fakultas Kedokteran Universitas Sumatera Utara. Halaman 1-10.
Karsono, B. (2009). Aspek Selular dan Molekular Kanker. Dalam: Sudoyo, A. W., editor. Buku Ajar Ilmu Penyakit Dalam. Jilid I. Edisi V. Jakarta: Fakultas Kedokteran Universitas Indonesia. Halaman 1414-1415.
Katzung, B. G. (2001). Farmakologi Dasar dan Klinik. Buku 1. Jakarta: Salemba Medika. Halaman 301, 480-481, 496.
Kissane, J. M. (1990). The Breast in Anderson’s Pathology. Volume II. Edisi IX. Missouri: Mosby. Halaman 1726-1728.
Krötz, F., Schiele, T. M., Klauss, V., dan Sohn, H. (2005). Selective COX-2 Inhibitors and Risk of Myocardial Infarction. Journal of Vascular
74
Kumar, V., Abbas, A. K., dan Fausto, N. (2005). Pathologic Basis for Disease. Edisi VII. Philadelphia: Elsevier Saunders. Halaman 26-28.
Li, Q., Guo, D., Dong, Z., Zhang, W., Zhang, L., Huang, S. M., et al. (2013). Ondansetron can Enhance Cisplatin-Induced Nephrotoxicity via Inhibition of Multiple Toxin and Extrusion Proteins (MATEs). Toxicology and
Applied Pharmacology. 273(1): 100-109.
Lindley, C., Hamilton, G., McCune, J. S., Faucette, S., Shord, S. S., Hawke, R. L., et al. (2002). The Effect of Cyclophosphamide with and without Dexamethasone on Cytochrome P450 3A4 and 2B6 in Human Hepatocytes. Drug Metabolism and Disposition. 30(7): 814-821.
Muchatuta, N. A., dan Paech, M. J. (2009). Management of Postoperative Nausea and Vomiting Focus on Palonosetron. Therapeutics and Clinical Risk
Management. 5(1): 21-34.
Muhartono., Hanriko, R. (2012). Korelasi antara Imunoekspresi p53 dan Respons Kemoterapi Neoadjuvan Regimen Fluorourasi, Adriamisin dan Siklofosfamid pada Karsinoma Duktus Payudara Invasif. Majalah
Kedokteran Bandung. 44(1): 13-18.
Rasjidi, I. (2009). Deteksi Dini dan Pencegahan Kanker pada Wanita. Jakarta: Agung Seto. Halaman 4.
Restifo, N. P., dan Wunderlich, J. R. (2001). Essentials of Immunology. Dalam: DeVita, V. T. Jr., Hellman, S., dan Rosenberg, S. A., editor. Cancer:
Principles & Practice of Oncology. Edisi V. Philadelphia: Lippincott
Williams & Wilkins. Halaman 43-73.
Robbin, S. L., Cotran, R. S., dan Kumar, V. (1994). Dasar Patologik Penyakit. Jilid 1. Jakarta: Bina Rupa Aksara. Halaman 135-166.
Robby. (2014). Prevalensi Penyakit Kanker di Indonesia, Tinggi. Diakses dari http://harianterbit.com/read/2014/05/09/1966/29/29/-Prevalensi-Penyakit-kanker-di-Indonesia-Tinggi pada tanggal 1 Juni 2014.
Samuel. (2011). Temu Pasien Kanker Payudara: Komitmen, Kualitas dan
Kepatuhan. Diakses dari http://www.sanofi.co.id/l/id/in/download.jsp?
file=AE5CE358-C0F2-47ED-907D-8CA7158072C8.pdf pada tanggal 1 April 2014.
Sari, I. P. (2004). Penelitian Farmasi Komunitas dan Klinis. Yogyakarta: Gajah Mada University Press. Halaman 44.
75
Silbernagl S., dan Lang, F. (2000). Color Atlas of Pathophysiology. Germany: Thieme. Halaman 152-155.
Singh, M. S., Francis, P. A., dan Michael, M. (2011). Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes. The Breast. 20: 111-118.
Sobin, L. H., dan Wittekind, C. H. (2002). International Union Against Cancer
(UICC): TNM Classification of Malignant Tumours. Edisi VI. New York:
John Wiley & Sons, Inc. Halaman 131-141.
Stokloza, T. dan Golab, J. (2005). Prospect for p53 Based Cancer Therapy. Acta
Biochimica Polonica. 52(2): 321-328.
Strand, L. M., Cipolle, R. J., Morley, P. C., Ramsey, R., dan Lamsam, G. D. (1990). Drug-Related Problems: Their Structure and Function. DICP The
Annals of Pharmacotherapy. 24(11): 1093-1097.
Strom, B. L., dan Kimmel, S.I. (2006). Textbook of Pharmacoepidemiology. London: John Wiley & Sons Ltd. Halaman 19-20.
Sudewi, N. P., Tumberlaka, A. R., dan Windiastuti, E. (2007). Kejadian Demam Neutropenia pada Keganasan. Sari Pediatri. 8(3): 68-72.
Tan, P. H. (2001). Pathology of Ductal Carcinoma In Situ of the Breast: A Heterogenous Entity in Need of Greater Understanding. Annals of the
Academy of Medicine, Singapore. 30(6): 671-676.
Todorova, I., Simeonova, G., Simeonov, R., dan Dinev, D. (2005). Efficacy and Toxicity of Doxorubicin and Cyclophosphamide Chemotherapy in Dogs with Spontaneous Mammary Tumours. Trakia Journal of Sciences. 3(5): 51-58.
Ulialbab, A., Priyanto, A. D., Maulana, H. I., Puspitasari, F. R., Fitriani, E., dan Estiasih T. (2012). Pemberian Tablet Effervescent Rosella Ungu Menurunkan Nilai MDA (Malondialdehid) Tikus Wistar yang Dipapar Minyak Jelantah. The Indonesian Journal of Public Health. 9(1): 81-86.
Whiteside, T. L., dan Haberman, R. B. (2003). Characteristics of Natural Killer Cell and Limphokine-activated Killer Cell. Dalam: Oettgen H. F., editor.
Human Cancer Immunology. Philadelphia: W. B. Saunders Company.
Halaman 718-744.
Wolfe, M. M., Lichtenstein, D. R., dan Singh, G. (1999). Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs. The New England Journal of
76
